Variants of the primate vesicular monoamine transporter-2

Brain Res Mol Brain Res. 2005 Oct 3;139(2):251-7. doi: 10.1016/j.molbrainres.2005.05.028.

Abstract

The vesicular monoamine transporter-2 (VMAT2) sequesters monoamine neurotransmitters into vesicles and prevents neurotoxicity. Human or monkey striatum generated three VMAT2 immunoreactive proteins of approximately 75 kDa, approximately 52-55 kDa, and approximately 45 kDa. The approximately 55-kDa band is considered the unglycosylated native protein. Deglycosylation of the VMAT2 from striatum or human VMAT2 expressed in HEK293 cells yielded a approximately 45-kDa, but not a 55-kDa immunoreactive band. We investigated this apparent mismatch between observed molecular size and predicted size.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Analysis of Variance
  • Animals
  • Base Sequence
  • Blotting, Western / methods
  • Cloning, Molecular / methods
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Dopamine / pharmacokinetics
  • Glycosylation
  • Humans
  • Macaca mulatta
  • Macromolecular Substances / metabolism
  • Models, Molecular
  • Molecular Weight
  • Mutagenesis
  • Phosphorylation
  • Transfection
  • Tritium / pharmacokinetics
  • Vesicular Monoamine Transport Proteins / chemistry
  • Vesicular Monoamine Transport Proteins / genetics
  • Vesicular Monoamine Transport Proteins / metabolism*

Substances

  • Macromolecular Substances
  • Vesicular Monoamine Transport Proteins
  • Tritium
  • Dopamine